2014-07-30T10:37:31-05:00 2013-12-31 521446779 JOHNSON LAMBERT LLP 700 SPRING FOREST ROAD SUITE 115 RALEIGH NC 27609 990 2013-01-01 030466352 GYNECOLOGIC ONCOLOGY GROUP GYNE 4107217126 2127 ESPEY COURT NO 100 CROFTON MD 21114 MARY C SHARP CHIEF FINANCIAL OFFICER 4107217126 2014-07-30 1 JOHN HUSKINS P01081531 9197196400 2014-07-30 2013 2015-11-30 17:44:51Z PHILIP J DISAIA MD 2127 ESPEY COURT NO 100 CROFTON MD 21114 29960775 0 X WWW.GOG.ORG X 2002 DC THE GYNECOLOGIC ONCOLOGY GROUP'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 13 12 30 0 0 0 14956713 15999497 4787054 10924197 314967 725161 16536 83018 20075270 27731873 0 0 0 0 2843053 2775108 0 0 267681 15082288 19763365 17925341 22538473 2149929 5193400 42848053 51932649 12572380 12876192 30275673 39056457 X THE GYNECOLOGIC ONCOLOGY GROUP (GOG) IS A NON-PROFIT ORGANIZATION (NATIONAL) WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. THE GROUP (GYNECOLOGIC ONCOLOGISTS, MEDICAL ONCOLOGISTS, PATHOLOGISTS, RADIATION ONCOLOGISTS, NURSES, STATISTICIANS, BASIC SCIENTISTS, QUALITY OF LIFE EXPERTS, DATA MANAGERS AND ADMINISTRATIVE PERSONNEL) IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. 0 0 22265705 10924197 THE GROUP IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2013 GYNECOLOGIC ONCOLOGY GROUP CONDUCTED CLINICAL TRIALS THROUGH OUR 60 PLUS MEMBER INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 22265705 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 46 0 1 30 1 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 MD X MARY C SHARP CFO 4107217126 2127 ESPEY COURT SUITE 100 CROFTON MD 21114 PHILIP J DISAIA MD PRESIDENT 20.00 X X 0 0 0 LARRY J COPELAND MD VICE PRESIDENT/TREASURER 13.00 X X 0 0 0 ROBERT C PARK MD IMMEDIATE PAST PRESIDENT 1.00 X 0 0 0 D SCOTT MCMEEKIN MD SECRETARY 1.00 X X 0 0 0 CAROL AGHAJANIAN DIRECTOR 1.00 X 0 0 0 JOHN BLESSING PHD DIRECTOR 1.00 X 0 0 0 PAUL A DISILVESTRO DIRECTOR 1.00 X 0 0 0 SHASHIKANT B LELE MD DIRECTOR 1.00 X 0 0 0 HELEN E MICHAEL DIRECTOR 1.00 X 0 0 0 BRADLEY J MONK MD DIRECTOR 1.00 X 0 0 0 SUSAN NOLTE PHD DIRECTOR 1.00 X 0 0 0 MARCUS E RANDALL DIRECTOR 1.00 X 0 0 0 PEETER ROSE DIRECTOR 1.00 X 0 0 0 MARY C SHARP CHIEF FINANCIAL OFFICER 35.00 X 226080 0 45780 LAURA REESE EXECUTIVE DIRECTOR 35.00 X 176520 0 28947 DENISE MACKEY DIRECTOR OF ADMINISTRATION 35.00 X 133377 0 24453 KATHY SHUMAKER DIRECTOR OF DEVELOPMENT 35.00 X 119458 0 15934 655435 0 115114 4 0 1 0 BUCHANNAN INGERSOLL & ROONEY 1700 K STREET NW STE 300 WASHINGTON DC 20006 LEGAL & CONSULTING SERVICES 493618 BIOLOGICS INC 120 WESTON OAKS COURT CARY NC 27513 RESEARCH SERVICES 220843 DR PHILIP J DISAIA MD 12132 SKYLINE DR SANTA ANA CA 92705 CONSULTING SERVICES 179730 3 15377895 621602 15999497 INDUSTRY REVENUE 900099 10535284 10535284 REGISTRATION FEES 900099 361113 361113 EXHIBIT FEES 900099 27800 27800 10924197 758255 758255 2195808 2228902 -33094 -33094 -33094 MISCELLANEOUS 900099 83018 83018 83018 27731873 10924197 0 808179 477327 458234 19093 1646806 963877 541728 141201 164605 94332 56675 13598 332776 236773 74913 21090 153594 101570 39119 12905 216866 194326 22540 58532 25857 32675 642321 277167 365154 58 58 179920 113506 59122 7292 19390 8640 10750 283085 211485 71600 382774 303008 67951 11815 714401 427492 251390 35519 62219 62219 PURCHASE SERVICE AGREEM 11148239 11148239 CONSORTIUMS 5946255 5939109 7146 HONORARIA 66373 32632 32612 1129 MISCELLANEOUS 35287 31306 3981 7645 1729458 -1721813 22538473 22265705 5087 267681 192000 208609 8850955 10494515 2935793 2501051 71624 68962 29740643 37582414 1025584 344226 700000 31454 32872 42848053 51932649 2716193 4006618 9856187 8869574 12572380 12876192 X 30275673 39056457 30275673 39056457 42848053 51932649 5193400 3587384 0 X 0 1 X 1 1 1 X 15606369 19305875 18301937 14956713 15999497 84170391 15606369 19305875 18301937 14956713 15999497 84170391 84170391 570476 840561 706217 780162 758255 3655671 5875 73224 190429 16536 83018 369082 88195144 40488436 0.95440 0.95610 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 31319257 3587384 3587384 27731873 0 27731873 22538473 0 22538473 0 22538473 PART X, LINE 2: MANAGEMENT HAS CONCLUDED THAT GOG HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2013 OR 2012. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES PURCHASE SERVICE AGREEMENTS 583560 0 0 0 0 0 0 583560 0 583560 0 0 0 0 0 0 X X 0 0 0 0 0 0 0 0 0 MARY C SHARP CHIEF FINANCIAL OFFICER 218706 0 7374 0 0 0 22608 0 23172 0 271860 0 0 0 LAURA REESE EXECUTIVE DIRECTOR 169926 0 6594 0 0 0 17652 0 11295 0 205467 0 0 0 DENISE MACKEY DIRECTOR OF ADMINISTRATION 130421 0 2956 0 0 0 13338 0 11115 0 157830 0 0 0 PHILIP J DISAIA PRESIDENT 179730 CONSULTING AGREEMENT 0 FORM 990, PART VI, SECTION A, LINE 6 GOG IS A MEMBERSHIP ORGANIZATION. CLASSES OF MEMBERS ARE AS FOLLOWS: INSTITUTIONAL FULL MEMBERS, INSTITUTIONAL PROVISIONAL MEMBERS, INSTITUTIONAL PROBATIONARY MEMBERS, AND INDIVIDUAL MEMBERS. OF THESE, INSTITUTIONAL FULL MEMBERS ARE THE ONLY CLASS THAT CAN VOTE. FORM 990, PART VI, SECTION A, LINE 7A INSTITUTIONAL FULL MEMBERS ELECT THE MEMBERS OF THE BOARD BY MAJORITY VOTE. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE GROUP CHAIR, AND ON AN INTERIM BASIS. THE GROUP CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE CEO AND TREASURER ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK.